Twelve of 32 patients lost HBeAg and DNA polymerase from their serum after completing antiviral therapy with interferon and/or adenine arabinoside. Three lost serum HBsAg as well. Loss of corresponding viral markers from hepatic tissue was also seen. There was improvement in symptoms, hepatic tests,
Problems with animal models of chronic liver disease: Suggestions for improvement in standardization
β Scribed by Kevin D. Mullen; Arthur J. McCullough
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 448 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A proper diagnosis of cirrhosis is essential for the management of patients with chronic liver diseases. We assessed the accuracy of liver stiffness measurement by Fibroscan for the diagnosis of cirrhosis in 1,257 patients with chronic liver diseases of various causes enrolled in a prospective multi
Mayo risk score, United Network for Organ Sharing (UNOS) status, Organ Sharing.
Although adult-to-adult living donor liver transplantation (ALDLT) has shown comparable outcomes to deceased donor liver transplantation, the outcome of patients with a high MELD score (ΟΎ25) and a small-for-size graft (SFSGΟ½0.8% of graft-torecipient weight ratio) is not known. For 7 years, 167 conse
The ability of the Model for End-Stage Liver Disease (MELD) score to capture the urgency of transplantation may not be generalizable to patients with primary sclerosing cholangitis (PSC) because these patients face unique risks of death or removal from the liver transplant waitlist due to disease-sp